Cell-Signaling Molecule May Play Key Role in Development of Lupus Kidney Disease.
Volunteer for NIAID-funded clinical studies related to lupus on ClinicalTrials.gov.
Lupus, a disabling and life-threatening autoimmune disease, affects more than 1.5 million Americans, 90 percent of whom are women. It is two to three times more common among African Americans, Native Americans, Hispanics, and Asians, than among Caucasians.
From the National Institute of Arthritis and Musculoskeletal and Skin Diseases:
NIAID-supported research on autoimmune diseases, including lupus, focuses on
Read more about NIAID’s Role in Lupus Research.
Last Updated September 21, 2009
Last Reviewed June 21, 2009